Skip to main content
SpringerLink
Log in

Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced Hypercholesterolemia

  • Original Article
  • Published:
High Blood Pressure & Cardiovascular Prevention Aims and scope Submit manuscript

Abstract

Introduction

One of the most frequent side effect of oral contraceptives use is a stable alteration of the lipid profile. This could be even more relevant in women affected by polycystic ovary syndrome (PCOS).

Aim

Considering the importance of a balanced lipid profile in cardiovascular prevention and that the exposure to the drugs could be many years long, our aim was to investigate the possible beneficial effect of a largely tested low-dosed combined lipid-lowering nutraceutical on dyslipidemias induced by oestroprogestins prescribed to young women for different indications.

Methods

We prospectively enrolled 84 patients in primary cardiovascular disease prevention, with low estimated cardiovascular disease risk (<5 % according to the ESC/EAS guidelines), and LDL-C increased above normal value (LDL-C >130 mg/dL) after the use of at least two different oral oestroprogestins treatments. Forty-four women were prescribed oral oestroprogestins for PCOS, while 40 for pure contraception. The tested nutraceutical contained berberine 500 mg/tab and monacolins 3 mg/tab was prescribed to all enrolled patients, associated the previously prescribed standard lipid-lowering diet.

Results

After 3 months of nutraceutical treatment, we observed a significant improvement in BMI (−1.5 ± 0.8 %, p < 0.001), FPG (−6.9 ± 5.8 %, p < 0.001), HOMA index (−3.5 ± 5.6 %, p < 0.001), TC (−20.1 ± 6.6 %, p < 0.001), LDL-C (−25.3 ± 8.9 %, p < 0.001), HDL-C (+14.1 ± 2.2 %, p < 0.001), TG (−29.9 ± 25.2 %, p < 0.001) and hsCRP (−2.5 ± 2.4 %, p = 0.019). Similar results have been obtained even repeating the analysis by subgroups, beyond hsCRP that significantly improved in PCOS patients compared to both the baseline and the non-PCOS group.

Conclusion

It appears that the tested combined lipid-lowering nutraceutical is able to equally improve lipid metabolism in oral contraceptive induced hypercholesterolemia in women affected or not by PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, Chapron C. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 2013;14(3):291–305.

    Article  CAS  PubMed  Google Scholar 

  3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–9.

    Article  CAS  PubMed  Google Scholar 

  4. Soares GM, Vieira CS, de Paula Martins W, Dos Reis RM, de Sá MF, Ferriani RA. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome. Int J Clin Pract. 2009;63(1):160–9.

    Article  CAS  PubMed  Google Scholar 

  5. Kaplan B. Desogestrel, norgestimate, and gestodene: the newer progestins. Ann Pharmacother. 1995;29(7–8):736–42.

    CAS  PubMed  Google Scholar 

  6. Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Palombo-Kinne E, Mellinger U, Lange E, Kuhl H. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use. Contraception. 2010;81(1):57–61.

    Article  CAS  PubMed  Google Scholar 

  7. Barreiros FA, Guazzelli CAF, Barbosa R, Torloni MR, Barbieri M, Araujo FF. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism. Contraception. 2011;84(2):155–9.

    Article  CAS  PubMed  Google Scholar 

  8. Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N Engl J Med. 1983;308(15):862–7.

    Article  CAS  PubMed  Google Scholar 

  9. Godsland I, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 1990;323(20):1375–81.

    Article  CAS  PubMed  Google Scholar 

  10. Crook D, Godsland IF, Wynn V. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Am J Obstet Gynecol. 1988;158(6 Pt 2):1612–20.

    Article  CAS  PubMed  Google Scholar 

  11. Scharnagl H, Petersen G, Nauck M, Teichmann AT, Wieland H, März W. Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism. Contraception. 2004;69(2):105–13.

    Article  CAS  PubMed  Google Scholar 

  12. Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer WF, Mommers E. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care. 2011;16(6):444–57.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Crook D, Godsland I. Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Contraception. 1998;57(3):189–201.

    Article  CAS  PubMed  Google Scholar 

  14. Cicero AFG, Parini A, Rosticci M, Brancaleoni B, Derosa G, Grandi E, Borghi C. Effect of a lipid-lowering nutraceutical on pulse-wave-velocity in hypercholesterolemic patients with or without chronic kidney disease. Open Hypertens J. 2013;5:18–22.

    Google Scholar 

  15. Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC Committee for Practice Guidelines 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3–46.

    Article  CAS  PubMed  Google Scholar 

  16. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.

    Article  Google Scholar 

  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.

    Article  CAS  PubMed  Google Scholar 

  18. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity c-reactive protein assay. Clin Chem. 1999;45(12):2136–41.

    CAS  PubMed  Google Scholar 

  19. Cicero AFG, Tartagni E, Borghi C. Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction? J Clin Lipid. 2012;7(5):549–59.

    Article  CAS  Google Scholar 

  20. Trimarco B, Benvenuti C, Rozza F, Cimmino CS, Giudice R, Crispo S. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet. Med J Nutr Metab. 2011;4(2):133–9.

    Google Scholar 

  21. Pisciotta L, Bellocchio A, Bertolini S. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. Lipids Health Dis. 2012;11:123.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011;28(12):1105–13.

    Article  CAS  PubMed  Google Scholar 

  23. Cicero AFG, Derosa G, Borghi C. Red yeast rice and statin-intolerant patients. Am J Cardiol. 2010;105(10):1504.

    Article  PubMed  Google Scholar 

  24. Zanardi M, Quirico E, Benvenuti C, Pezzana A. Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancer. Minerva Ginecol. 2012;64(5):431–5.

    CAS  PubMed  Google Scholar 

  25. Cicero AFG, De Sando V, Benedetto D, Cevenini M, Grandi E, Borghi C. Long-term efficacy and tolerability of a largely marketed multicomponent nutraceutical in overweight and normoweight dyslipidaemic patients. Nutrafoods. 2012;11(2):15–21.

    Article  Google Scholar 

  26. Affuso F, Ruvolo A, Micillo F, Saccà L, Fazio S. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis. 2010;20(9):656–61.

    Article  CAS  PubMed  Google Scholar 

  27. Stovall DW, Bailey AP, Pastore LM. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J Womens Health. 2011;20(1):37–43.

    Article  Google Scholar 

  28. Affuso F, Mercurio V, Ruvolo A, Pirozzi C, Micillo F, Carlomagno G, Grieco F, Fazio S. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome. World J Cardiol. 2012;4(3):77–83.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012;166(1):99–105.

    Article  CAS  PubMed  Google Scholar 

  30. Meden-Vrtovec H, Vrtovec B, Osredkar J. Metabolic and cardiovascular changes in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2007;99(2):87–90.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical and Surgical Sciences Department, University of Bologna, S. Orsola-Malpighi Hospital, Via Albertoni, 15, 40138, Bologna, Italy

    Arrigo F. G. Cicero, Alessandra Reggi, Angelo Parini, Martino Morbini, Martina Rosticci, Elisa Grandi & Claudio Borghi

Authors
  1. Arrigo F. G. Cicero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Reggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angelo Parini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martino Morbini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martina Rosticci
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elisa Grandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Claudio Borghi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arrigo F. G. Cicero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cicero, A.F.G., Reggi, A., Parini, A. et al. Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced Hypercholesterolemia. High Blood Press Cardiovasc Prev 21, 221–226 (2014). https://doi.org/10.1007/s40292-014-0052-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40292-014-0052-5

Keywords

Search

Navigation